Enablex (darifenacin) Disease Interactions
There are 3 disease interactions with Enablex (darifenacin):
Darifenacin (Includes Enablex) ↔ gastric retention
Severe Potential Hazard, Moderate plausibility. Applies to: Gastrointestinal Obstruction, Ulcerative Colitis, Myasthenia Gravis, Constipation
Darifenacin is contraindicated in patients with gastric retention. Darifenacin, like other anticholinergic drugs, may decrease gastrointestinal motility and should be used with caution in patients with gastrointestinal obstructive disorders and conditions such as severe constipation, ulcerative colitis, and myasthenia gravis because of the risk of gastric retention.
Darifenacin (Includes Enablex) ↔ glaucoma
Severe Potential Hazard, Moderate plausibility. Applies to: Glaucoma (Narrow Angle)
Darifenacin is contraindicated in patients with uncontrolled narrow-angle glaucoma. It is recommended to use darifenacin with caution in patients being treated for narrow-angle glaucoma and only where the potential benefits outweigh the risks.
Darifenacin (Includes Enablex) ↔ urinary retention
Severe Potential Hazard, Moderate plausibility. Applies to: Urinary Retention
Darifenacin is contraindicated in patients with urinary retention. Darifenacin is a competitive muscarinic receptor antagonist. It is recommended to use darifenacin with caution in patients with clinically significant bladder outflow obstruction because of the risk of urinary retention.
Enablex (darifenacin) drug interactions
There are 788 drug interactions with Enablex (darifenacin)
Enablex (darifenacin) alcohol/food interactions
There is 1 alcohol/food interaction with Enablex (darifenacin)
More about Enablex (darifenacin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 20 Reviews
- Generic Availability
- Drug class: urinary antispasmodics
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.